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Summary Introduction
Autosomal recessive (AR) limb-girdle muscular dystro-The group of autosomal recessive (AR) muscular dystro-
phies (LGMDs) represent a heterogeneous group of dis-phies includes, among others, two main clinical entities,
eases, characterized by a primary and progressive musclethe limb-girdle muscular dystrophies (LGMDs) and the
degeneration of the pelvic and shoulder girdles. A widedistal muscular dystrophies. The former are character-
spectrum of clinical disability is observed, ranging fromized mainly by muscle wasting of the upper and lower
very mild to severe forms (Walton and Gardner-Medwinlimbs, with a wide range of clinical severity. This clinical
1988; Bushby and Beckmann 1995).heterogeneity has been demonstrated at the molecular
Within the last few years, six genes that are responsi-level, since the genes for six AR forms have been cloned
ble for the AR LGMDs have been mapped and/orand/or have been mapped to 15q15.1 (LGMD2A),
cloned, conﬁrming their clinical heterogeneity at the mo-2p12-16 (LGMD2B), 13q12 (LGMD2C), 17q12-
lecular level. These six different forms have been namedq21.33 (LGMD2D), 4q12 (LGMD2E), and 5q33-34
chronologically, according to their gene identiﬁcation,(LGMD2F). The AR distal muscular dystrophies origi-
as follows: LGMD2A at 15q15.1 (Beckmann et al. 1991;nally included two subgroups, Miyoshi myopathy, char-
Richard et al. 1995), LGMD2B at 2p12-16 (Bashir etacterized mainly by extremely elevated serum creatine
al. 1994), LGMD2C at 13q12 (Othmane et al. 1992;kinase (CK) activity and by a dystrophic muscle pattern,
Noguchi et al. 1995), LGMD2D at 17q12-q21.33 (Rob-and Nonaka myopathy, which is distinct from the others
erds et al. 1993, 1994; McNally et al. 1994), LGMD2Ebecause of the normal to slightly elevated serum CK
at 4q12 (Bo¨nnemann et al. 1995; Lim et al. 1995), andlevels and a myopathic muscle pattern with rimmed vac-
LGMD2F at 5q33-34 (Nigro et al. 1996a, 1996b;uoles. With regard to our unclassiﬁed AR LGMD fami-
Passos-Bueno et al. 1996b). Except for the LGMD2Blies, analysis of the affected sibs from one of them (fam-
gene, all the other LGMD genes have been cloned. Theily LG61) revealed some clinical and laboratory ﬁndings
gene responsible for LGMD2A encodes calpain 3, or(early involvement of the distal muscles, mildly elevated
CANP3, a muscle-speciﬁc protease (Richard et al.serum CK levels, and rimmed vacuoles in muscle biop-
1995), whereas the genes that cause LGMD2C–sies) that usually are not observed in the analysis of
LGMD2F encode proteins of the dystrophin-glycopro-patients with LGMD2A–LGMD2F. In the present in-
tein complex (DGC) (Roberds et al. 1993; McNally etvestigation, through a genomewide search in family
al. 1994; Bo¨nnemann et al. 1995; Lim et al. 1995; No-LG61, we demonstrated linkage of the allele causing this
guchi et al. 1995; Richard et al. 1995; Nigro et al.form of muscular dystrophy to a 3-cM region on 17q11-
1996b).12. We suggest that this form, which, interestingly, clini-
The DGC is a large complex formed by dystrophincally resembles AR Kugelberg-Welander disease, should
and its associated proteins (DAPs) and glycoproteinsbe classiﬁed as LGMD2G. In addition, our results indi-
(DAGs) (Campbell 1995; Ozawa et al. 1995; Wortoncate the existence of still another locus causing severe
1995). The DAPs (a-, b1-, and b2-syntrophin and dys-LGMD.
trobrevin) are arranged in the syntrophin complex (Ad-
ams et al. 1993; Ahn et al. 1994; Peter et al. 1994; Yang
et al. 1994; Sadoulet-Puccio et al. 1996). The DAGs
are distributed between two subgroups, the dystroglycan
complex (a- and b-dystroglycan) (Ibraghimov-Beskrov-Received February 20, 1997; accepted for publication May 2, 1997.
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de Sa˜o Paulo, Rua do Matao, 277, CEP 05508-900 Sa˜o Paulo, Brazil. (Campbell 1995; Ozawa et al. 1995). The DGC estab-
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protecting muscle ﬁbers frommechanical damage during a rapid progression, with the proximal muscles of the
legs, the small hand muscles, and the arm and neckcontractions (Campbell 1995). It recently has been dem-
onstrated that pathogenic mutations in the a-, b-, g-, muscles being involved at an early stage; (3) normal or
mildly elevated serum CK levels; and (4) a myopathicand d-sarcoglycan genes are responsible for LGMD2D,
LGMD2E, LGMD2C, and LGMD2F, respectively muscle pattern (with no apparent ﬁber necrosis and re-
generation) and the presence of rimmed vacuoles as a(Roberds et al. 1994; Bo¨nnemann et al. 1995; Lim et al.
1995; Noguchi et al. 1995; Nigro et al. 1996a). LGMD prominent feature (Nonaka et al. 1981; Isaacs et al.
1988; Sunohara et al. 1989; Yamanouchi et al. 1994;caused by a defect in any of the four components of the
sarcoglycan complex has been classiﬁed as sarcoglyca- Murakami et al. 1995). The distinction between DMRV
and hereditary inclusion body myopathy (HIBM), whichnopathy.
LGMD patients who have mutations in either the are both the result of AR inheritance, is very important
(Nonaka et al. 1981; Argov and Yarom 1984). HIBMLGMD2A locus or the LGMD2B locus have, in the ma-
jority of cases, a relatively mild phenotype—that is, they patients present with progressive muscular weakness,
normal or mildly increased serum CK levels, and a myo-are able to walk unassisted after the age of 16 years
(Beckmann et al. 1991; Bashir et al. 1994; Passos-Bueno pathic muscle pattern with rimmed vacuoles. However,
the distinguishing features of this disorder, as comparedet al. 1995a, 1996a; Richard et al. 1995). On the other
hand, patients with any of the four sarcoglycanopathies with those of other myopathies, are the sparing of the
quadriceps and the age at onset, which is usually 20–usually have a severe phenotype associated with total or
partial deﬁciency of a-sarcoglycan in the muscle (Rob- 40 years of age (Argov and Yarom 1984; Mitrani-Ro-
senbaum et al. 1996). The gene that causes HIBM,erds et al. 1994; Bo¨nnemann et al. 1995, 1996; Lim et al.
1995; Noguchi et al. 1995; Passos-Bueno et al. 1995b; which apparently has been reported only among individ-
uals of Persian Jewish descent, recently was mapped toMcNally et al. 1996; Nigro et al. 1996a; Vainzof et al.
1996). 9p1-q1 (Mitrani-Rosenbaum et al. 1996).
We have identiﬁed 26 families with AR LGMD (21AR–muscular dystrophy patients with involvement of
both the shoulder and pelvic girdles but with atrophy with mild forms and 5 with severe forms), on the basis
of clinical evolution, high serum CK levels, and the anal-beginning in the hands or in the feet have been reported
in previous studies (Nonaka et al. 1981; Argov and ysis of muscle biopsies (including the assessment of dys-
trophin and of the four sarcoglycans). Linkage analysisYarom 1984; Markesbery and Criggs 1986; Miyoshi et
al. 1986; Isaacs et al. 1988; Walton and Gardner-Med- of these 26 families has demonstrated the existence of
at least another locus, since 3 families still were unlinkedwin 1988; Sunohara et al. 1989; Yamanouchi et al.
1994). These families originally had been classiﬁed as to any known LGMD loci, as well as to the HIBM locus
(Bo¨nnemann et al. 1996; McNally et al. 1996; Passos-having one of the two forms of distal muscular dystro-
phy, Miyoshi myopathy (MM) or Nonaka myopathy Bueno et al. 1996a, 1996b; E. S. Moreira, M. Zatz, and
M. R. Passos-Bueno, unpublished data). Analysis of(also known as ‘‘distal myopathy with rimmed-vacuole
formation’’ [‘‘DMRV’’]) (Nonaka et al. 1981; Miyoshi muscle biopsies from these three kindreds, which were
all positive for the sarcoglycan complex, revealed theet al. 1986).
MM is characterized by (1) very high serum creatine presence of a great number of rimmed vacuoles in one
of them (family LG61). Since family LG61 is largekinase (CK) activity; (2) muscle weakness and atrophy
most marked in the legs, with relative sparing of the enough for mapping through linkage analysis, we per-
formed a genomewide search in this family. The resultsarms, neck, and small hand muscles; and (3) a dystro-
phic muscle pattern, with ﬁber necrosis and regeneration suggest the existence of another locus for AR LGMD at
17q11-12.(Miyoshi et al. 1986; Bejaoui et al. 1995). The MM gene
recently was mapped to 2p12-14, to the same region as
that of the gene for the LGMD2B form (Bejaoui et al. Subjects and Methods
1995). Weiler et al. (1996) described a large inbred ab-
Subjectsoriginal Canadian kindred with AR muscular dystrophy
also linked to this same chromosome 2p region. Interest- Three AR LGMD families (LG6, LG11, and LG61)
reported in previous studies (Passos-Bueno et al. 1996a,ingly, seven individuals presented an LGMD phenotype
and two an MM phenotype. These authors demon- 1996b) were included in the present analysis. Diagnosis
was based on clinical examination and course of thestrated that four LGMD patients and the two MM pa-
tients were homozygous for the same haplotype, sup- disease, family history, serum CK levels, and assessment
of dystrophin through immunocytochemistry/westernporting the hypothesis that LGMD2B and MM may be
caused by mutations in the same gene. blotting of muscle biopsies. Serum CK analysis was per-
formed by use of Sigma kits; normal levels are consid-DMRV is characterized by (1) onset in the distal mus-
cles of the legs, in the second or third decade of life; (2) ered to be £10 sigma units (SU)/ml for adults and £20
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Table 1SU/ml for children. Five of the six affected sibs in family
LG61, as well as the three patients in family LG11,
Size and Frequency of the Alleles That Are Segregating with the
recently have been clinically and neurologically reexam- Disease Allele, in Families LG11 and LG61
ined by one of us (S.K.M.). Muscle strength was assessed
Sizein accordance with the manual muscle test, which is
Marker and Allele(s)a (bp) Frequencybased on the Medical Research Council’s recommenda-
tions. Muscle biopsies of biceps were performed on at
D17S1867:
least one individual from each family. Dystrophin and 2 98 .22
a-sarcoglycan immunoﬂuorescence analyses were per- 3 96 .54
D17S250:formed as reported in previous studies (Vainzof et al.




DNA was extracted from whole blood, according to D17S946:
standard protocols (Miller et al. 1988). For the ge- 2 140 .06
4 136 .31nomewide search, DNA samples were analyzed by PCR
D17S1818:ampliﬁcation using microsatellite markers purchased
2 147 .05from Research Genetics and from Isogen. For reﬁnement 6 135 .21
of the candidate area, markers were selected from the D17S1814:
study by Dib et al. (1996). Standard protocols were 2 162 .25
8 150 .32used for PCR reactions. The products were visualized
on 6.5% denaturing gels, which were dried and exposed
a The allele numbers correspond to those shown in the haplotypesto x-ray ﬁlms for 2-24 h, as reported in a previous study of ﬁgure 2.
(Passos-Bueno et al. 1995b).
Linkage Analysis
to perform ankle dorsiﬂexion. Difﬁculty with walkingTwo-point linkage analysis was performed by use of
on the heels appeared prior to difﬁculty with walkingthe computer program MLINK (Lathrop et al. 1984),
on the toes. Extraocular and facial muscles were sparedwith an estimated gene frequency of .001 for the disease
in all the patients. In ﬁve sibs, who recently have beenallele and with equal recombination for both sexes. An
clinically and neurologically reassessed (table 3), theequal frequency of the alleles for most of the markers
neck muscles are only very mildly affected or not af-was considered, although we are aware that this could
fected. In the upper limbs, proximal muscle atrophy ishave inﬂated LOD scores (Terwilliger and Ott 1994).
marked, whereas, in the lower limbs, proximal and dis-Allele frequencies for the markers mapped to the candi-
tal muscle atrophy is evident, which is in accordancedate region were estimated on the basis of the analysis of
with the pattern of muscle weakness observed in both86–100 chromosomes from normal Caucasian subjects
limb girdles (table 3). It is interesting that in patient II-3,from our population (table 1). The sizes of the alleles
who shows the mildest clinical evolution, the proximalwere measured through comparison with the DNA se-
muscles of the upper and lower limbs are less affectedquence of the bacteriophage M13mp18 (United States
than the distal muscles (table 3). The tendon reﬂexes areBiochemical).
abolished, without involvement of sensory and cranial
nerves or of coordination. In addition, foot-drop is aResults
common feature in all of these ﬁve patients. Four of the
six affected sibs are already in a wheelchair. No evidencePedigree and Clinical Description of Family LG61
of cardiac disease was detected. CK levels were elevatedFamily LG61 is a Caucasian nonconsanguineous kin-
3–17-fold in the ﬁrst stages of the disease, but they havedred of Italian ancestry. The parents (66 and 69 years
decreased, as the patients have aged, to almost normalof age) had a total of eight offspring—two of which are
levels in those patients already in a wheelchair (table 2).unaffected (39 and 44 years of age) and six of which
are affected (27–43 years of age). The main clinical
Muscle Pathologyﬁndings for all the patients are described in table 2.
This family was ﬁrst seen in our center 20 years ago. The analysis of a muscle biopsy, from patient II-8 of
family LG61, showed round-shaped ﬁbers, with aThe mean age at onset was 12.5 years, which is when
the patients showed difﬁculty with walking, running, marked variation in ﬁber size. Necrotic and regenerating
ﬁbers were found, with an increased number of centraland climbing stairs. They report that at the same time
or soon after the ﬁrst signs were noted, they were unable myonuclei. Inﬁltration of connective tissue also was ob-
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Table 2
Main Clinical Findings in the LG61 Patients
CK LEVEL
(1 NORMAL)
CURRENT AGE AGE AT ONSET WHEELCHAIR CONFINEMENT
PATIENT (years) (years) 1976 1990 1997 (AGE [years])
II-2 43 15 5.4 1.6 1.3 Yes (39)
II-3 41 13 4.5 3.8 4.2 No
II-5 37 13 10.4 2.5 1.2 Yes (31)
II-6 36 9 17.5 4.0 2.0 Yes (34)
II-7 33 13 3.5 3.5 2.0 Yes (31)
II-8 27 12 4.0 3.1 4.7 No
served. One rimmed vacuole per ﬁber was detected in a additional candidate regions, where the syntrophin, dys-
troglycan, and HIBM genes have been mapped (Passos-great proportion of the muscle cells (ﬁg. 1A). There was
no predominance of type 1 or type 2 ﬁbers and no type Bueno et al. 1996a, 1996b; E. S. Moreira, M. Zatz, and
M. R. Passos-Bueno, unpublished data). Therefore, a ge-grouping (ﬁg. 1B). Dystrophin and a-sarcoglycan
showed a positive sarcolemmal staining through immu- nomewide search was performed for this genealogy.
A total of 402 markers (spaced 5–10 cM) were testednohistochemical studies.
in this kindred. Evidence of linkage was observed with
Linkage Analysis the microsatellite marker D17S250 (Zmax Å 3.26; u Å
.00), which is located at 17q11-12. The following addi-In a previous study, family LG61 had been excluded
for the six known AR LGMD loci, as well as for eight tional marker sequences near this locus were genotyped:
D17S1824–3 cM–D17S1800–2 cM–D17S1880–3
cM–D17S1850; D17S1833–2 cM–D17S1872–1 cM–
D17S933–1 cM–D17S1867–1 cM–D17S1851;Table 3




MOVEMENT TESTED II-2 II-3 II-5 II-6 II-8
Neck ﬂexion 5 4 4 5 4
Neck extension 5 5 5 5 5
Shoulder abduction 1 3 1 1 2
Shoulder external rotation 1 5 1 1 2
Elbow ﬂexion 0 5 0 0 2
Elbow extension 2 5 2 2 4
Wrist ﬂexion 4 4 4 4 5
Wrist extension 2 3 2 2 4
Thumb abduction 5 4 2 3 5
Hip ﬂexion 1 2 1 1 2
Hip extension 1 2 1 1 2
Knee ﬂexion 0 3 0 0 2
Knee extension 2 3 2 2 3
Ankle dorsiﬂexion 0 0 0 0 0
Ankle plantarﬂexion 0 1 0 0 0
Toe ﬂexion 0 0 0 0 0
Toe extension 0 0 0 0 0
Figure 1 A, Muscle biopsy, from patient II-8 of family LG61,a 0 Å no movement; 1 Å ﬂicker of movement; 2 Å movement of
the joint when the effect of gravity is eliminated; 3 Å movement showing evidence of rimmed vacuoles in affected ﬁbers (haematoxylin
and eosin). B, Muscle biopsy, from patient II-8 of family LG61, show-through full range of the joint, against gravity but not against resis-
tance; 4 Å movement of the joint, against gravity and against added ing no predominance of type 1 or type 2 ﬁbers (ATPase stain at pH
9.4). Bar Å 25 mm.resistance; and 5 Å full strength.
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Figure 2 Haplotypes with markers from the 17q11-12 region in the two LGMD2G families. The haplotype of individual I-1 from family
LG11 was deduced from the family’s descendants. The haplotype or the portions of it presumed to be ancestrally associated with the disease
in the families are boxed; a partially boxed haplotype indicates that it was not possible to establish with certainty the haplotype at risk (owing
to lack of informativeness of the parents). An asterisk (*) indicates a marker for which the exact position is unknown; the position estimate
was based on the analysis of recombinants found in this genealogy (see text).
D17S946–1 cM–D17S1818–1 cM–D17S1814–1 cM– The markers from the candidate region also were
tested in two other families (LG6 and LG11), which areD17S1787–1 cM–D17S1789; and D17S932–1 cM–
D17S1861. Although the exact position of D17S250 is unlinked to any known LGMD or candidate loci
(Passos-Bueno et al., 1996a, 1996b; E. S. Moreira, M.unknown, we have suggested that this marker may lie
between D17S1867 and D17S1814, on the basis of anal- Zatz, and M. R. Passos-Bueno, unpublished data). Posi-
tive LOD scores were detected in only one familyysis of recombinants observed in family LG61 (ﬁg. 2).
Results of two-point linkage analysis between these (LG11), which was genotyped further for the other 16
markers from the 17q11-12 region (table 4; ﬁg. 2).microsatellites and the disease gene in family LG61 are
described in table 4. Conﬁrmation of linkage (LOD In family LG11, although the LOD score was õ3.00,
owing to the small family size, no recombinants werescore ú3.00) was obtained by use of two other markers,
D17S1851 and D17S1818. found within an interval of 5 cM. In addition, homozy-
gosity was observed between the markers D17S250 andTwo important recombinations were observed in this
genealogy, involving affected individual II-8 and one D17S1814. Interestingly, this haplotype, which was not
found in our control population (data not shown), wasof his normal sibs, individual II-1. In individual II-8, a
recombination between D17S1867 and D17S1851 observed in heterozygosity, in all the affected sibs from
family LG61 (ﬁg. 2).placed the gene distal to D17S1867, whereas, in the
normal sib (individual II-1), the recombination between
D17S1814 and D17S1818 positioned the gene proximal Discussion
to D17S1814. Therefore, the gene must lie in the interval
between D17S1867 and D17S1814. Homozygosity was In the present report, we were able to demonstrate
linkage to 17q11-12 of another subtype of AR muscularfound only for the 151-bp allele of marker D17S250;
however, this allele is the most common in our popula- dystrophy. Interestingly, this new locus has been
mapped near the a-sarcoglycan gene (Roberds et al.tion (ﬁg. 2; table 1).
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Table 4
Results of Two-Point Linkage Analysis between the Disease Gene and 17q11-12 Markers
LOD SCORE FOR FAMILY LG11, AT u Åa LOD SCORE FOR FAMILY LG61, AT u Å
MARKER .00 .01 .05 .10 .20 .00 .01 .05 .10 .20
D17S1824 .55 .54 .49 .43 .30 0 02.49 0.60 .05 .40
D17S1800 0 0.57 .03 .21 .25 0 02.49 0.60 .05 .40
D17S1880 0 0.57 .02 .19 .22 1.15 1.14 1.06 .96 .73
D17S1850 0 01.00 0.39 0.19 0.06 1.15 1.14 1.06 .96 .73
D17S1833 0 0.96 0.35 0.15 0.03 1.15 1.14 1.06 .96 .73
D17S1872 0 0.57 .02 .19 .22 0 02.49 0.60 .05 .40
D17S933 0 01.00 0.38 0.17 0.04 0 02.49 0.60 .05 .40
D17S1867 1.45 1.42 1.29 1.13 .78 0 0.49 .68 .99 .98
D17S250 1.45 1.42 1.30 1.13 .79 3.26 3.20 2.95 2.63 1.94
D17S1851 1.45 1.42 1.30 1.13 .79 3.26 3.20 2.95 2.63 1.94
D17S946 1.45 1.42 1.30 1.13 .79 1.45 1.43 1.33 1.20 .91
D17S1818 1.45 1.42 1.30 1.13 .79 3.26 3.20 2.95 2.63 1.94
D17S1814 1.45 1.42 1.30 1.13 .79 0 1.50 1.96 1.95 1.58
D17S1787 0 0.57 .03 .21 .25 1.15 1.14 1.06 .96 .73
D17S1789 .55 .54 .49 .43 .30 1.15 1.14 1.06 .96 .73
D17S932 0 0.84 0.24 0.05 .04 0 1.50 1.96 1.95 1.58
D17S1861 .55 .54 .49 .43 .30 0 1.50 1.96 1.95 1.58
a Homogeneity test (Terwilliger and Ott 1994): x2 Å 1.385; P ú .05. Heterogeneity test (Terwilliger and Ott 1994): x2 Å 22.87; P õ .001.
1994); however, it is located at least 9 cM apart from the sarcoglycanopathies. It is important to point out that
the patients noted difﬁculty with walking on the heelsthe a-sarcoglycan gene.
Although family LG61 is not consanguineous, we prior to difﬁculty with walking on the toes. This obser-
vation suggests that the tibial anterior muscle was af-have found homozygosity with the 151-bp allele of
marker D17S250. Since this allele is the most common fected before the gastrocnemius, which is just the oppo-
site of what is described for LGMD2B or MM patients.in our population, this data does not support evidence
for linkage disequilibrium. Therefore, on the basis of On the other hand, the observation that the neck mus-
cles, as well as the small hand muscles, were only slightlythe analysis of recombinants observed in this kindred,
we have estimated that the candidate region for this new or not involved and the ﬁnding that the muscle pathol-
ogy was typically dystrophic differs from DMRV. Inlocus spans Ç3 cM. Several genes lie within this area;
however, their products are not speciﬁcally expressed in addition, the patients reported here were conﬁned to
wheelchairs at least 18 years after the ﬁrst signs, whereasthe muscle; therefore, they were not considered to be
good functional candidate genes for this disease (OMIM DMRV leads to the loss of ambulation within 10 years
after its onset (Murakami et al. 1995). These observa-1996).
The phenotypes of the affected patients from this 17q- tions suggest that the family reported here has a different
muscle disease.linked family were relatively mild until the third decade
of life. However, four of the patients were conﬁned to In addition, one of our still-unlinked LGMD genealo-
gies (LG11) also may be linked to this locus. The threea wheelchair before 40 years of age, and the youngest
brother, who is currently 27 years of age, walks with affected sibs from this family also show a relatively mild
phenotype, with onset of the disease at the beginning ofgreat difﬁculty and only with support, suggesting that
he will not be able to walk much longer. On the other the second decade of life. Two of them, who are 19 and
24 years of age, are still walking without difﬁculties;hand, patient II-3 (tables 2 and 3), who is currently 41
years of age, is showing a milder course, illustrating the however, the third one, who is 23 years of age, is still
walking without support but is unable to climb stairs.intrafamilial variability in the expression of this disease
gene. Although there is severe involvement of the proxi- Although in an earlier stage, the pattern of muscle
involvement in this family seems to be very similar tomal muscles of the upper and lower limbs, the marked
weakness in the distal muscles of the legs, the moderately that presented by family LG61, in particular with regard
to the initial weakness of the tibial anterior muscle (tableincreased serum CK levels, and the presence of rimmed
vacuoles in the muscle biopsy distinguish this form of 5). The patients’ serum CK levels are only slightly ele-
vated (31 SU). Rimmed vacuoles were observed in theirARmuscular dystrophy from LGMD2A, LGMD2B, and
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Table 5 occurrence of both LGMD and MM phenotypes in one
family and by the demonstration that these two pheno-
Manual Muscle-Strength Evaluation of the Patients
types might have been caused by mutations in the samefrom Family LG11
gene (Weiler et al. 1996). Another example is the large
STRENGTH RATING, inbred Finnish family reported by Udd et al. (1991). In
FOR EACH PATIENTa this kindred, two different muscular manifestations, one
compatible with LGMD and the other with distal myop-
MOVEMENT TESTED II-2 II-3 II-4
athy, are segregating (Udd et al. 1991; Udd 1992).
On the basis of our ﬁndings and of the above-de-Neck ﬂexion 5 5 5
Neck extension 5 5 5 scribed observations, we propose to classify this new
Shoulder abduction 5 1 5 form of AR muscular dystrophy as LGMD2G. The fact
Shoulder external rotation 5 1 5 that this 17q-linked family (LG61), which is of Italian
Elbow ﬂexion 5 0 5
ancestry, is nonconsanguineous suggests that mutationsElbow extension 5 1 5
in this locus may be relatively common. Therefore, weWrist ﬂexion 4 4 5
Wrist extension 4 4 4 think that it will be extremely important to test this
Thumb abduction 5 4 4 new locus in AR–muscular dystrophy families who are
Hip ﬂexion 4 1 3 positive for the sarcoglycan complex independently of
Hip extension 4 0 3
early distal muscle involvement. Interestingly, there areKnee ﬂexion 4 0 3
some patients diagnosed as having Kugelberg-WelanderKnee extension 4 1 3
Ankle dorsiﬂexion 0 0 2 disease (KW; also known as ‘‘spinal muscular atrophy
Ankle plantarﬂexion 4 3 4 type III’’) who have slightly elevated serum CK levels
Toe ﬂexion 4 4 4 and rimmed vacuoles in their muscle biopsies, thus pre-
Toe extension 4 0 0
senting with a phenotype resembling that of the LGMD
family (LG61) described here (Fukahara et al. 1980;a 0 Å no movement; 1 Å ﬂicker of movement; 2 Å movement of
the joint when the effect of gravity is eliminated; 3 Å movement Aubry et al. 1995; Lefebvre et al. 1995; Rodrigues et
through full range of the joint, against gravity but not against resis- al. 1996). In most of the KW patients, the disease is due
tance; 4 Å movement of the joint, against gravity and against added to mutations in the survival motor-neuron (SMN) gene;
resistance; and 5 Å full strength.
however, in 5%–10% of these patients, KW seems to
be caused by mutations at another locus (Aubry et al.
1995; Lefebvre et al. 1995; Rodrigues et al. 1996; Wang
et al. 1996). The possibility that the pathology in thesemuscle biopsies; however, these vacuoles were very rare.
The clinical evolution and the laboratory ﬁndings are cases also is caused by mutations in the LGMD2G gene
should be considered.compatible with those of the 17q-linked kindred (LG61)
reported here. In addition, it is important to point out The identiﬁcation of the genetic defects responsible
for the different types of LGMD has been extremelythat these patients share the same haplotype as those of
family LG61, which further supports the hypothesis that important for the enhancement of our comprehension
of the underlying pathological mechanisms. Therefore,the disease in this family also may have been caused by
mutations in this 17q locus. However, deﬁnite proof the cloning of the gene that, when mutated, causes
LGMD2G will be of fundamental importance.will only be possible after the identiﬁcation of this gene.
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